CHANCE trial: early short-term dual antiplatelet treatment for stroke prevention.

Mednet Member

Neurology · University of Virginia, School of Medicine

I usually look at the stroke mechanism in making my decisions about DAPT rather than just relying on the NIHSS alone. If the mechanism is ICAD, branch atherosclerotic disease, SVD (with infarct extension), embolism from the aortic arch plaque, subclavian artery heterogenous plaque, extra-cranial ver...